914397-21-0

Basic information

• Product Name: Benzaldehyde, 5-bromo-2-fluoro-4-hydroxy-
• Synonyms: Benzaldehyde, 5-bromo-2-fluoro-4-hydroxy-;5-Bromo-2-fluoro-4-hydroxy-benzaldehyde
• CAS NO: 914397-21-0
• Molecular Formula: C₇H₄BrFO₂
• Molecular Weight: 219.0078632
• Mol File: 914397-21-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzaldehyde, 5-bromo-2-fluoro-4-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 5-bromo-2-fluoro-4-hydroxy-(914397-21-0)
• EPA Substance Registry System: Benzaldehyde, 5-bromo-2-fluoro-4-hydroxy-(914397-21-0)

Safety Data

• Hazardous Substances Data: 914397-21-0(Hazardous Substances Data)

Upstream product

• 348-27-6 2-fluoro-4-hydroxybenzaldehyde 
• 473417-48-0 5-bromo-2-fluoro-4-methoxybenzaldehyde 
• 331-64-6 2-fluoro-4-methoxy-benzaldehyde 

Downstream Products

• 914397-22-1 4-(benzyloxy)-5-bromo-2-fluorobenzaldehyde 

Relevant articles and documents

PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to pyrimidine derivatives of formula (I) wherein (R1)n, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.

BIARYL OXYACETIC ACID COMPOUNDS

The present invention provides biaryl oxyacetic acid compounds which may be useful for treating inflammatory disorders, including disorders affecting the respiratory system and skin. The compounds provided include those of the general formula I.

2-AMINOQUINAZOLINE DERIVATIVES

2-Aminoquinazoline derivatives represented by the general formula (I) or pharmacologically acceptable salts thereof: (I) wherein R1 and R2 are each independently hydrogen, substituted or unsubstituted lower alkyl, or the like; X is a bond or CR7aR7b (wherein R7a and R7b are each independently hydrogen or the like); when X is a bond, R3 is substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group, while when X is CR7aR7b, R3 is substituted or unsubstituted lower alkoxy, substituted or unsubstituted aryl, or the like; R4 is hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or the like; and R5 is hydrogen, substituted or unsubstituted aryl, or the like.